Evotec Aktiengesellschaft (Evotec) is a biopharmaceutical company engaged in discovering and developing novel small molecule drugs. The company’s proprietary platform targets central nervous system related diseases and pipeline products focus on oncology, inflammation, metabolic disease and cardiovascular diseases. Evotec enters into research and development collaborations with various pharmaceutical and biotechnology companies for its product candidates. It has a strategic alliance with Roche. Evotec has two NMDA NR2-B antagonists in clinical development and has also completed Phase I studies of EVT 401, a P2X7 antagonist. The company operates in Europe, the UK, Asia and the US. Evotec is headquartered in Hamburg, Germany

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days.

Evotec Aktiengesellschaft SWOT Analysis report provides you a strategic analysis and detailed overview of the company’s businesses and operations.

In this report, our analysts reveal the company’s business strategy, strengths, weakness, opportunities and threats and detailed information such as :
- Key events associated with the company,
- Major products, services and brands of the company,
- Key competitors,
- Key executives, biographies and employment history,
- Personnel heading key departments and functions,
- Important locations and subsidiaries
- Financial analysis and ratios based on the annual financial statements published by the company including a 5 years history.
- Interim ratios for the last five interim periods

You get also in deepth information about Evotec Aktiengesellschaft operations to identify potential customers, partners and suppliers. Evotec Aktiengesellschaft business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Latest Company Developments:

Table Of Contents


I - Evotec Aktiengesellschaft Company Profile

Key Information
Overview
Key Employees and biographies
Operational Heads
Main Products and Services
Historical Data
Company Mission Statement
Operations And Subsidiaries
Headquarter

II - Evotec Aktiengesellschaft Company Analysis

Business Description
Company Vision and Strategy
SWOT Analysis
Strengths, Weaknesses, Opportunities, Threats
Competitive Landscape

III - Evotec Aktiengesellschaft Financial Analysis and Performance Charts

Financial Ratios
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

World Therapy: Fibromyalgia – Pipeline Review, H1 2012

World Therapy: Fibromyalgia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Fibromyalgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

World Therapy: Choroidal Neovascularization – Pipeline Review, H1 2012

World Therapy: Choroidal Neovascularization – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Choroidal Neovascularization, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

Hyperglycemia - Pipeline Review, H1 2014

Hyperglycemia - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • April 2014
  • by Global Markets Direct

Hyperglycemia - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Hyperglycemia - Pipeline Review, H1 2014', provides an overview of the Hyperglycemia's therapeutic pipeline. This report provides ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.